Send the link below via email or IMCopy
Present to your audienceStart remote presentation
- Invited audience members will follow you as you navigate and present
- People invited to a presentation do not need a Prezi account
- This link expires 10 minutes after you close the presentation
- A maximum of 30 users can follow your presentation
- Learn more about this feature in our knowledge base article
Transcript of Genetic Engineering
petroleum, allowing for more efficient oil spill
clean up STIFLES RESEARCH LACK OF INDEPENDENT VARIATION CREATES MONOPOLIES EXORBITANT FEES OWNERSHIP OF KNOWLEDGE SAM DAVIS, URI BULOW, DARYL GOLDMAN, MATTHEW SMELSER REFERENCES (2010). DNA: A patent problem. Daily Breeze. Retrieved from http://www.dailybreeze.com/opinions/ci_14909562.
(2010). Myriad Genetics falls as gene patents are voided. Business Week. Retrieved from http://www.businessweek.com/ap/financialnews/D9EP20LO0.htm.
Kesselheim, A.S. & Mello, M.M. (2010). Gene Patenting – Is the Pendulum Swinging Back. New England Journal of Medicine Online. Retrieved from http://content.nejm.org/cgi/content/full/NEJMp1004026.
Noonan, K.E. (2010). The Fantastical Economics of the Gene Patenting Debate. Patent Docs. Retrieved from http://www.patentdocs.org/2010/04/the-fantastical-economics-of-the-gene-patenting-debate.html.
patent - a document granting an inventor sole rights to an invention genetic testing - analysis of genetic code to show increased liklihood of disease monopoly - exclusive control of a commodity; outlawed in regard to business HISTORY BACKGROUND BRCA1 & BRCA2 - tumor suppresor genes that encode a protein. Mutations allow uncontrolled duplication. Women with mutation have 60% increase in breast cancer risk and 25-55% incrrease for ovarian cancer. SIMILARITY TO DRUG PATENTING tumor suppressor gene - a gene that
prevents uncontrolled cell division